# Innate Pharma SA: Form 6-K, filed Jun 4, 2024

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2024-06-04
- Accepted by EDGAR: Jun 4, 2024, 06:03 ET
- Period: 2024-06-04
- Accession: 0001598599-24-000044
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000159859924000044/a6k-iphx240604.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000159859924000044/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000159859924000044/a6k-iphx240604.htm

Filed Jun 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001598599-24-000044. Last ingested by Listed: Nov 12, 2026, 17:11 ET. No prices; not investment advice.